Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Award - Doctoral Foreign Study Award (DFSA)

Direct Payment

$105,000.00

Studies of the structure, function and regulation of the ATR-ATRIP complex

FY 2018-19

Summary
The complete and accurate replication of the genetic information in our DNA prior to each cycle of cell division is critical to our health and survival. Changes to the integrity of our genome can result from ongoing intracellular and environmental sources of DNA damage that, if left unrepaired, could disrupt key cellular processes. Importantly, such damage is often a barrier to the completion of DNA replication, a phenomenon known as replication stress. Human cells have mechanisms of preserving genomic integrity during replication that are controlled by a protein called ATR (short for 'ataxia telangiectasia and Rad3-related'). ATR sits atop a signaling network known as the DNA damage response that detects, signals and resolves DNA damage and replication stress. Upon recognition of aberrant DNA structures, ATR binds to DNA near affected sites where it gets "turned on" by interaction with other signaling molecules. ATR proceeds to coordinate a number of processes required for repairing the damage and restarting the replication process. This study will address two important aspects of ATR function at the molecular level: its ability to bind to damaged DNA, and how it becomes activated in response to damage. In recent years, ATR has been proposed as a potential anti-cancer drug target for a number of reasons. Cancer cells are prone to replication stress and thus highly reliant on ATR for their survival. The DNA repair capacity of ATR signaling mediates resistance to chemotherapy, a mainstay of cancer treatment whose efficacy is dependent on the ability to cause lethal amounts of DNA damage. Taken together, pharmacological inhibition of ATR can be effective on two fronts: by targeting an essential process on which cancer cells depend, and sensitizing the cells to existing chemotherapeutic agents. A better mechanistic understanding of ATR will allow for the rational design of new drugs and open up new cancer treatment options.
Program
Doctoral Award - Doctoral Foreign Study Award (DFSA)
Location
New York, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
404192
Name
Li Buren
Region
New York
Country
United States of America
Orgtype
Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Studies of the structure, function and regulation of the ATR-ATRIP complex
Programtype2
Studentship Programs
Orgnameinp2
Direct Payment
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Doctoral Foreign Study Award (DFSA)
Keyworddelim
Cryo-Em; Dna Damage Response; Genomic Integrity; Kinase; Molecular Mechanism; Replication Stress; Structural Biology
Abstract
The complete and accurate replication of the genetic information in our DNA prior to each cycle of cell division is critical to our health and survival. Changes to the integrity of our genome can result from ongoing intracellular and environmental sources of DNA damage that, if left unrepaired, could disrupt key cellular processes. Importantly, such damage is often a barrier to the completion of DNA replication, a phenomenon known as replication stress. Human cells have mechanisms of preserving genomic integrity during replication that are controlled by a protein called ATR (short for 'ataxia telangiectasia and Rad3-related'). ATR sits atop a signaling network known as the DNA damage response that detects, signals and resolves DNA damage and replication stress. Upon recognition of aberrant DNA structures, ATR binds to DNA near affected sites where it gets "turned on" by interaction with other signaling molecules. ATR proceeds to coordinate a number of processes required for repairing the damage and restarting the replication process. This study will address two important aspects of ATR function at the molecular level: its ability to bind to damaged DNA, and how it becomes activated in response to damage. In recent years, ATR has been proposed as a potential anti-cancer drug target for a number of reasons. Cancer cells are prone to replication stress and thus highly reliant on ATR for their survival. The DNA repair capacity of ATR signaling mediates resistance to chemotherapy, a mainstay of cancer treatment whose efficacy is dependent on the ability to cause lethal amounts of DNA damage. Taken together, pharmacological inhibition of ATR can be effective on two fronts: by targeting an essential process on which cancer cells depend, and sensitizing the cells to existing chemotherapeutic agents. A better mechanistic understanding of ATR will allow for the rational design of new drugs and open up new cancer treatment options.
Competitiondate
201810
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Li, Buren
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~
Direct Payment - $105,000 Grant (2018-19) | Canada Spends